Concord Biotech Pre-IPO Tearsheet
Concord Biotech Ltd (658823Z IN) is looking to raise about US$250m in its upcoming India IPO. The deal will be run by Kotak, Citi, and Jefferies.
377 Views
𝛼SK or SearchENTITY
Concord Biotech (CONCORDB IN)
Concord Biotech (CONCORDB IN)
31
Analysis
Industrials • India
Concord Biotech is a biopharmaceutical company specializing in the research, development, manufacture, and sale of fermentation-based Active Pharmaceutical Ingredients (APIs) and high-quality finished formulations. The company's products span therapeutic areas such as immunosuppressants, oncology, antifungal, and antibacterial treatments. Concord Biotech was founded in 1984 and is headquartered in Ahmedabad, Gujarat, India.
morex